NLRP3 positron emission tomography tracer - Ventus Therapeutics
Latest Information Update: 17 May 2023
At a glance
- Originator Ventus Therapeutics
- Class Imaging agents; Radiopharmaceutical diagnostics
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Parkinson's disease